Pharmaceutical Innovation
Experienced Biotech Executives Launch New Rare Disease Startup
Another rare disease startup is entering the market, this time backed by a group of executives who have been here before. Mendra, a new biotech led by former BioMarin and Escient Pharmaceuticals executives, has raised $82 million in a Series A round led by OrbiMed, 8VC, and 5AM Ventures. The company says the capital will…
Chinese Biotech Growth Forces U.S. Companies to Innovate Faster
David Li, founder of Meliora Therapeutics, quickly learned that the U.S. biotech space isn’t isolated anymore. While looking at drug targets for his new company, he noticed that a lot of the same targets were already being pursued by Chinese firms. Curious, he went to Shanghai and Suzhou. What he saw surprised him. “They’re all…
